Akebia Therapeutics initiated at Buy by WestPark Capital
Akebia Therapeutics was initiated at Buy by WestPark Capital, according to Benzinga ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.